<?xml version="1.0" encoding="UTF-8"?>
<ref id="B39-pharmaceutics-13-00379">
 <label>39.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Komatsu</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Katsuyama</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Uezono</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Sakurada</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Tsuzuki</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Hamamura</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Bagetta</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Sakurada</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Sakurada</surname>
    <given-names>T.</given-names>
   </name>
  </person-group>
  <article-title>Possible involvement of the peripheral Mu-opioid system in antinociception induced by bergamot essential oil to allodynia after peripheral nerve injury</article-title>
  <source>Neurosci. Lett.</source>
  <year>2018</year>
  <volume>686</volume>
  <fpage>127</fpage>
  <lpage>132</lpage>
  <pub-id pub-id-type="doi">10.1016/j.neulet.2018.08.053</pub-id>
  <pub-id pub-id-type="pmid">30201308</pub-id>
 </element-citation>
</ref>
